Literature DB >> 14532148

Metalloproteinases, inflammation, and rheumatoid arthritis.

F F Mohammed1, D S Smookler, R Khokha.   

Abstract

Ideally, the inflammatory response occurs rapidly to terminate infection. It also must halt in a timely manner to stop this reaction from inflicting self damage. Such a highly regulated process results from altering balances in pro- and anti-inflammatory signals orchestrated by multiple cell types and factors within the tissue microenvironment. The discovery of new substrates of metalloproteinases within this microenvironment has disclosed a new function in inflammation. The role of these proteases now extends beyond extracellular matrix remodelling enzymes to that of mediators of inflammatory signals involving various chemokines and cytokines. As natural inhibitors of these metalloproteinases, TIMPs have the potential of regulating the inflammatory response and affecting diseases such as rheumatoid arthritis. TIMP-3, in particular, stands out as an important regulator of inflammation with its ability to specifically inhibit proinflammatory cytokines and tissue destruction in the joint.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532148      PMCID: PMC1766743          DOI: 10.1136/ard.62.suppl_2.ii43

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

Review 1.  Physiology of cytokine pathways in rheumatoid arthritis.

Authors:  W P Arend
Journal:  Arthritis Rheum       Date:  2001-02

2.  TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.

Authors:  W H Yu; S Yu; Q Meng; K Brew; J F Woessner
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 3.  Matrix metalloproteinases: effectors of development and normal physiology.

Authors:  T H Vu; Z Werb
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

4.  TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

Authors:  M Kashiwagi; M Tortorella; H Nagase; K Brew
Journal:  J Biol Chem       Date:  2001-01-23       Impact factor: 5.157

Review 5.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

6.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

7.  Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.

Authors:  J H Ruth; M V Volin; G K Haines; D C Woodruff; K J Katschke; J M Woods; C C Park; J C Morel; A E Koch
Journal:  Arthritis Rheum       Date:  2001-07

8.  Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).

Authors:  G Hashimoto; T Aoki; H Nakamura; K Tanzawa; Y Okada
Journal:  FEBS Lett       Date:  2001-04-13       Impact factor: 4.124

9.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

Authors:  K J Garton; P J Gough; C P Blobel; G Murphy; D R Greaves; P J Dempsey; E W Raines
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

10.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.

Authors:  G A McQuibban; J H Gong; E M Tam; C A McCulloch; I Clark-Lewis; C M Overall
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

View more
  46 in total

1.  Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.

Authors:  Aruna K Behera; Ethan Hildebrand; Joanna Scagliotti; Allen C Steere; Linden T Hu
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases.

Authors:  Allison E Schafer; Burns C Blaxall
Journal:  J Cardiovasc Pharmacol       Date:  2017-07       Impact factor: 3.105

3.  Regulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytes.

Authors:  J Deschner; B Rath-Deschner; S Agarwal
Journal:  Osteoarthritis Cartilage       Date:  2005-11-14       Impact factor: 6.576

4.  Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.

Authors:  Elizabeth A Berger; Sharon A McClellan; Ronald P Barrett; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-18       Impact factor: 4.799

5.  AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis.

Authors:  Nikhlesh K Singh; Dong Van Quyen; Venkatesh Kundumani-Sridharan; Peter C Brooks; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

6.  TIMP3: a physiological regulator of adult myogenesis.

Authors:  Huijie Liu; Shuen-Ei Chen; Bingwen Jin; James A Carson; Airu Niu; William Durham; Jian-Yang Lai; Yi-Ping Li
Journal:  J Cell Sci       Date:  2010-08-03       Impact factor: 5.285

7.  Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.

Authors:  Anne M Macgregor; Charles G Eberhart; Mostafa Fraig; Jie Lu; Marc K Halushka
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479

Review 8.  Imaging evaluation of inflammation in the musculoskeletal system: current concepts and perspectives.

Authors:  Guillaume Bierry; Jean-Louis Dietemann
Journal:  Skeletal Radiol       Date:  2013-05-19       Impact factor: 2.199

9.  Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis.

Authors:  Laura Mäkitalo; Maija Piekkala; Merja Ashorn; Mikko Pakarinen; Antti Koivusalo; Riitta Karikoski; Johanna Natunen; Ulpu Saarialho-Kere; Risto Rintala; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

10.  Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.

Authors:  Maung-Maung Thwin; Eleni Douni; Pachiappan Arjunan; George Kollias; Prem V Kumar; Ponnampalam Gopalakrishnakone
Journal:  Arthritis Res Ther       Date:  2009-09-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.